期刊文献+

含SARS CoV RNA病毒样颗粒的构建和表达 被引量:5

Construction and expression of virus-like particles containing SARS CoV RNA
下载PDF
导出
摘要 目的 :构建并表达含有SARS冠状病毒RNA片断的抗核糖核酸酶的病毒样颗粒 .方法 :通过克隆大肠杆菌噬菌体MS2的装配蛋白和壳蛋白基因以及SARS冠状病毒RNA聚合酶基因片段 ,将这些基因连接到载体pTrc99a上表达 ,并进行纯化、定量分析、RT PCR检测和稳定性试验 .结果 :获得病毒样核蛋白颗粒 ,在 37℃稳定性可达到 30d ,能抵抗核糖核酸酶降解 .结论 :该病毒样核蛋白颗粒稳定、安全、可靠 ,可作为SARS冠状病毒RT PCR检测、定量分析的有效阳性参考品 . AIM: To construct and express RNase-resistant virus-like particles containing the RNA fragments of SARS CoV. METHODS: The primers of MS2 assembly protein gene, coat protein gene and the fragment of SARS Cov RNA polymerase gene were synthesized according to their sequences from Genbank data and were used to amplify their cDNAs by RT-PCR. These cDNAs were purified with SABC's ResincolumTM system for DNA purification from agarose gel. Expression vector pTrc99a and their cDNA fragments were ligated together with T4 DNA ligase after digestion with restriction enzymes. The prokaryotic expression was obtained by the transformation of the recombinant plasmid constructed above into E.coli JM109. The obtained virus-like particles were purified and tested by quantitative analysis, RT-PCR and stable experiment. RESULTS: The RNase-resistant virus-like particles containing the RNA fragments of SARS CoV was successfully constructed and remained stable for 30 days at 37℃. CONCLUSION: The new-type virus-like particles can be conveniently used as positive control of SARS clinical nucleic diagnostic reagents.
出处 《第四军医大学学报》 CAS 北大核心 2004年第20期1858-1861,共4页 Journal of the Fourth Military Medical University
关键词 SAILS 逆转录聚合酶链反应 RNA 病毒样颗粒 核糖核酸酶类 SARS reverse transcriptase polymerase chain reaction RNA, virus-like particles ribonucleases
  • 相关文献

参考文献9

  • 1WalkerPeach CR, Winkler M, DuBois DB, et al. Ribonuclease-resistant RNA controls (Armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus[J]. Clin Chem, 1999; 45: 2079-2085.
  • 2Neumann G, Watanabe T, Kawaoka Y. Plasmid-driven formation of influenza virus-like particles [J]. J Virol, 2000; 74(1):547-551.
  • 3Drosten C, Seifried E, Roth WK, et al. TaqMan 5′-Nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening [J]. J Clin Microbiol, 2001; 39: 4302-4308.
  • 4Callahan JD, Wu SJ, Dion-Schultz A, et al. Development and evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for Dengue virus[J]. J Clin Microbiol, 2001; 39: 4119-4124.
  • 5Lochridge VP, Hardy ME. Snow Mountain virus genome sequence and virus-like particle assembly [J]. Virus Genes, 2003; 26:71-82.
  • 6Muriaux D, Mirro J, Harvin D, et al. RNA is a structural element in retrovirus particles [J]. Proc Natl Acad Sci USA, 2001; 24(98):5246-5251.
  • 7Chen XS, Garcea RL, Goldberg I, et al. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16[J]. Mol Cell, 2000; 5:557-567.
  • 8Joshi SM, Vogt VM. Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli [J]. J Virol, 2000; 74(21):10260-10268.
  • 9Xiang J, Wunschmann S, George SL, et al. Recombinant hepatitis C virus-like particles expressed by baculovirus: Utility in cell-binding and antibody detection assays [J]. J Med Virol, 2002; 68:537-543.

同被引文献42

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部